Fig. 1From: The potential anticancer effect of bee venom in combination with sorafenib against HepG2 cell lines via induction of apoptosis and autophagy candidate genesThe sigmoidal dose–response curve for MTT assay showing IC50 values after 24-h treatment with A BV, B Sorf and C BV/Sorf (equal concentrations of each combined in a ratio of 1:1) on HepG2 cells. Data were normalized to untreated control cells and expressed as the mean ± SE. Samples ran in triplicate in 3 independent experimentsBack to article page